These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 31594564)

  • 1. Interlaboratory assessment of droplet digital PCR for quantification of BRAF V600E mutation using a novel DNA reference material.
    Dong L; Wang X; Wang S; Du M; Niu C; Yang J; Li L; Zhang G; Fu B; Gao Y; Wang J
    Talanta; 2020 Jan; 207():120293. PubMed ID: 31594564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients.
    Tzanikou E; Haselmann V; Markou A; Duda A; Utikal J; Neumaier M; Lianidou ES
    Clin Chem Lab Med; 2020 Oct; 58(11):1799-1807. PubMed ID: 31953992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing.
    Milosevic D; Mills JR; Campion MB; Vidal-Folch N; Voss JS; Halling KC; Highsmith WE; Liu MC; Kipp BR; Grebe SKG
    Clin Chem; 2018 Dec; 64(12):1732-1742. PubMed ID: 30237149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation and implementation of droplet digital PCR for the detection of BRAF mutations from cell-free DNA.
    Arnolda R; Howlett K; Chan T; Raleigh J; Hatzimihalis A; Bell A; Fellowes A; Sandhu S; McArthur GA; Fox SB; Dawson SJ; Hewitt C; Jones K; Wong SQ
    Pathology; 2022 Oct; 54(6):772-778. PubMed ID: 35618509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
    Li X; Du H; Luo J; Ding W; Lai B; He J; Xu S; Zhang Y
    J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
    Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
    Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.
    Reid AL; Freeman JB; Millward M; Ziman M; Gray ES
    Clin Biochem; 2015 Oct; 48(15):999-1002. PubMed ID: 25523300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations.
    Poole JC; Wu SF; Lu TT; Vibat CRT; Pham A; Samuelsz E; Patel M; Chen J; Daher T; Singh VM; Arnold LJ
    PLoS One; 2019; 14(10):e0223112. PubMed ID: 31581267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of the BRAF
    Ashida A; Sakaizawa K; Mikoshiba A; Uhara H; Okuyama R
    Int J Clin Oncol; 2016 Oct; 21(5):981-988. PubMed ID: 27041702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray-based analysis of the BRAF V600 mutations in circulating tumor DNA in melanoma patients.
    Emelyanova MA; Telysheva EN; Orlova KV; Ryabaya OO; Snigiryova GP; Abramov IS; Mikhailovich VM
    Cancer Genet; 2021 Jan; 250-251():25-35. PubMed ID: 33249369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of BRAF
    Pierry C; Caumont C; Blanchard E; Brochet C; Dournes G; Gros A; Bandres T; Verdon S; Marty M; Bégueret H; Merlio JP
    Virchows Arch; 2018 Feb; 472(2):247-258. PubMed ID: 28711990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.
    Tsao SC; Weiss J; Hudson C; Christophi C; Cebon J; Behren A; Dobrovic A
    Sci Rep; 2015 Jun; 5():11198. PubMed ID: 26095797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).
    Rassner M; Waldeck S; Follo M; Jilg S; Philipp U; Jolic M; Wehrle J; Jost PJ; Peschel C; Illert AL; Duyster J; Scherer F; von Bubnoff N
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.
    Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y
    Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors.
    Sanmamed MF; Fernández-Landázuri S; Rodríguez C; Zárate R; Lozano MD; Zubiri L; Perez-Gracia JL; Martín-Algarra S; González A
    Clin Chem; 2015 Jan; 61(1):297-304. PubMed ID: 25411185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interlaboratory Reproducibility of Droplet Digital Polymerase Chain Reaction Using a New DNA Reference Material Format.
    Pinheiro LB; O'Brien H; Druce J; Do H; Kay P; Daniels M; You J; Burke D; Griffiths K; Emslie KR
    Anal Chem; 2017 Nov; 89(21):11243-11251. PubMed ID: 28968098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection.
    Dong L; Wang S; Fu B; Wang J
    Sci Rep; 2018 Nov; 8(1):9650. PubMed ID: 30504843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma.
    Gouda MA; Polivka J; Huang HJ; Treskova I; Pivovarcikova K; Fikrle T; Woznica V; Dustin DJ; Call SG; Meric-Bernstam F; Pesta M; Janku F
    ESMO Open; 2022 Feb; 7(1):100357. PubMed ID: 34942440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of BRAF V600E mutation in fine-needle aspiration fluid of papillary thyroid carcinoma by droplet digital PCR.
    Xu X; Ma X; Zhang X; Cao G; Tang Y; Deng X; Kang Z; Li M; Guan M
    Clin Chim Acta; 2019 Apr; 491():91-96. PubMed ID: 30682328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay.
    Lyu N; Rajendran VK; Diefenbach RJ; Charles K; Clarke SJ; Engel A; ; Rizos H; Molloy MP; Wang Y
    Nanotheranostics; 2020; 4(4):224-232. PubMed ID: 32923312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.